{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:53:16Z","timestamp":1768575196137,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12033-023-00669-3","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T14:02:45Z","timestamp":1675692165000},"page":"1679-1692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Circ_TEX2 Functions as a Tumor Suppressor in Hepatoma via miR-96-5p\/SPRED1 Axis"],"prefix":"10.1007","volume":"65","author":[{"given":"Qinggong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4647-2674","authenticated-orcid":false,"given":"Wenbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"669_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/516S1a","volume":"516","author":"L Gravitz","year":"2014","unstructured":"Gravitz, L. (2014). Liver cancer. Nature, 516, S1\u2013S1.","journal-title":"Nature"},{"key":"669_CR2","volume-title":"StatPearls [Internet]","author":"KO Asafo-Agyei","year":"2021","unstructured":"Asafo-Agyei, K. O., & Samant, H. (2021). Portal vein thrombosis. StatPearls [Internet]. StatPearls Publishing."},{"key":"669_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"A Marengo","year":"2016","unstructured":"Marengo, A., Rosso, C., & Bugianesi, E. (2016). Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annual Review of Medicine, 67, 103\u2013117.","journal-title":"Annual Review of Medicine"},{"key":"669_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cld.2007.04.007","volume":"11","author":"AC Del Pozo","year":"2007","unstructured":"Del Pozo, A. C., & L\u00f3pez, P. (2007). Management of hepatocellular carcinoma. Clinics in Liver Disease, 11, 305\u2013321.","journal-title":"Clinics in Liver Disease"},{"key":"669_CR5","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya, N., Sawada, Y., Endo, I., Saito, K., Uemura, Y., & Nakatsura, T. (2015). Biomarkers for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology, 21, 10573\u201310583.","journal-title":"World Journal of Gastroenterology"},{"key":"669_CR6","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.3748\/wjg.v20.i15.4115","volume":"20","author":"A Raza","year":"2014","unstructured":"Raza, A., & Sood, G. K. (2014). Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World Journal of Gastroenterology, 20, 4115\u20134127.","journal-title":"World Journal of Gastroenterology"},{"key":"669_CR7","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3748\/wjg.v19.i37.6144","volume":"19","author":"JW Shin","year":"2013","unstructured":"Shin, J. W., & Chung, Y. H. (2013). Molecular targeted therapy for hepatocellular carcinoma: Current and future. World Journal of Gastroenterology, 19, 6144\u20136155.","journal-title":"World Journal of Gastroenterology"},{"key":"669_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-030-21540-8_11","volume-title":"Hepatocellular Carcinoma: Translational Precision Medicine Approaches","author":"A Mahipal","year":"2019","unstructured":"Mahipal, A., Kommalapati, A., Mehta, R., & Kim, R. D. (2019). Molecular-Targeted Therapies in Hepatocellular Carcinoma. In Y. Hoshida (Ed.), Hepatocellular Carcinoma: Translational Precision Medicine Approaches (pp. 225\u2013238). Humana Press."},{"key":"669_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbagrm.2015.07.007","volume":"1859","author":"KK Ebbesen","year":"2016","unstructured":"Ebbesen, K. K., Kjems, J., & Hansen, T. B. (2016). Circular RNAs: Identification, biogenesis and function. Biochimica et Biophysica Acta, 1859, 163\u2013168.","journal-title":"Biochimica et Biophysica Acta"},{"key":"669_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","volume":"98","author":"J Zang","year":"2020","unstructured":"Zang, J., Lu, D., & Xu, A. (2020). The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. Journal of Neuroscience Research, 98, 87\u201397.","journal-title":"Journal of Neuroscience Research"},{"key":"669_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.577938","volume":"7","author":"A Rajappa","year":"2020","unstructured":"Rajappa, A., Banerjee, S., Sharma, V., & Khandelia, P. (2020). Circular RNAs: Emerging role in cancer diagnostics and therapeutics. Frontiers in Molecular Biosciences, 7, 577938.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"669_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.697747","volume":"11","author":"R Liao","year":"2021","unstructured":"Liao, R., Liu, L., Zhou, J., Wei, X., & Huang, P. (2021). Current molecular biology and therapeutic strategy status and prospects for circRNAs in HBV-associated hepatocellular carcinoma. Frontiers in Oncology, 11, 697747.","journal-title":"Frontiers in Oncology"},{"key":"669_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-021-01417-4","volume":"20","author":"L He","year":"2021","unstructured":"He, L., Man, C., Xiang, S., Yao, L., Wang, X., & Fan, Y. (2021). Circular RNAs\u2019 cap-independent translation protein and its roles in carcinomas. Molecular Cancer, 20, 119.","journal-title":"Molecular Cancer"},{"key":"669_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-021-01145-8","volume":"14","author":"H Shen","year":"2021","unstructured":"Shen, H., Liu, B., Xu, J., Zhang, B., Wang, Y., Shi, L., et al. (2021). Circular RNAs: Characteristics, biogenesis, mechanisms and functions in liver cancer. Journal of Hematology & Oncology, 14, 134.","journal-title":"Journal of Hematology & Oncology"},{"key":"669_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.7150\/thno.53227","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu, H., Lan, T., Li, H., Xu, L., Chen, X., Liao, H., et al. (2021). Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics, 11, 1396\u20131411.","journal-title":"Theranostics"},{"key":"669_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang, G., Liang, M., Liu, H., Huang, J., Li, P., Wang, C., et al. (2020). CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/\u03b2-catenin pathway. Cell Death & Disease, 11, 1065.","journal-title":"Cell Death & Disease"},{"key":"669_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.21037\/atm.2020.03.06","volume":"8","author":"F Wang","year":"2020","unstructured":"Wang, F., Xu, X., Zhang, N., & Chen, Z. (2020). Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature. Annals of Translational Medicine, 8, 294.","journal-title":"Annals of Translational Medicine"},{"key":"669_CR18","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.3779","author":"M Wu","year":"2020","unstructured":"Wu, M., Sun, T., & Xing, L. (2020). Circ_0004913 inhibits cell growth, metastasis, and glycolysis by absorbing miR-184 to regulate HAMP in hepatocellular carcinoma. Cancer Biotherapy and Radiopharmaceuticals. https:\/\/doi.org\/10.1089\/cbr.2020.3779","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"669_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12935-020-01521-3","volume":"20","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Han, S., Li, M., Song, Y., & Qi, F. (2020). Circ_0004913 sponges miR-1290 and regulates FOXC1 to inhibit the proliferation of hepatocellular carcinoma. Cancer Cell International, 20, 431.","journal-title":"Cancer Cell International"},{"key":"669_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","volume":"60","author":"R Garzon","year":"2009","unstructured":"Garzon, R., Calin, G. A., & Croce, C. M. (2009). MicroRNAs in Cancer. Annual Review of Medicine, 60, 167\u2013179.","journal-title":"Annual Review of Medicine"},{"key":"669_CR21","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng, Y., & Croce, C. M. (2016). The role of MicroRNAs in human cancer. Signal Transduction and Targeted Therapy, 1, 15004.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"669_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","volume":"11","author":"W Si","year":"2019","unstructured":"Si, W., Shen, J., Zheng, H., & Fan, W. (2019). The role and mechanisms of action of microRNAs in cancer drug resistance. Clinical Epigenetics, 11, 25.","journal-title":"Clinical Epigenetics"},{"key":"669_CR23","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","volume":"8","author":"\u00c1 Nagy","year":"2018","unstructured":"Nagy, \u00c1., L\u00e1nczky, A., Menyh\u00e1rt, O., & Gy\u0151rffy, B. (2018). Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Science and Reports, 8, 9227.","journal-title":"Science and Reports"},{"key":"669_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153886","volume":"233","author":"HA El-Mahdy","year":"2022","unstructured":"El-Mahdy, H. A., Sallam, A. M., Ismail, A., Elkhawaga, S. Y., Elrebehy, M. A., & Doghish, A. S. (2022). miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathology, Research and Practice, 233, 153886.","journal-title":"Pathology, Research and Practice"},{"key":"669_CR25","first-page":"237","volume":"53","author":"N Iwai","year":"2018","unstructured":"Iwai, N., Yasui, K., Tomie, A., Gen, Y., Terasaki, K., Kitaichi, T., et al. (2018). Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma. International Journal of Oncology, 53, 237\u2013245.","journal-title":"International Journal of Oncology"},{"key":"669_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/hepr.13674","volume":"52","author":"T Matsui","year":"2022","unstructured":"Matsui, T., Hamada-Tsutsumi, S., Naito, Y., Nojima, M., Iio, E., Tamori, A., et al. (2022). Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma. Hepatology Research, 52, 93\u2013104.","journal-title":"Hepatology Research"},{"key":"669_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.21037\/atm-22-3147","volume":"10","author":"F Yuan","year":"2022","unstructured":"Yuan, F., Tang, Y., Cao, M., Ren, Y., Li, Y., Yang, G., et al. (2022). Identification of the hsa_circ_0039466\/miR-96-5p\/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis. Annals of Translational Medicine, 10, 769.","journal-title":"Annals of Translational Medicine"},{"key":"669_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1101\/gad.1839510","volume":"24","author":"T Phoenix","year":"2010","unstructured":"Phoenix, T., & Temple, S. (2010). Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. Genes & Development, 24, 45\u201356.","journal-title":"Genes & Development"},{"key":"669_CR29","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/hmg\/ddaa263","volume":"29","author":"Y Cui","year":"2020","unstructured":"Cui, Y., Ma, L., Schacke, S., Yin, J. C., Hsueh, Y. P., Jin, H., et al. (2020). Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway. Human Molecular Genetics, 29, 3793\u20133806.","journal-title":"Human Molecular Genetics"},{"key":"669_CR30","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.2147\/OTT.S106513","volume":"9","author":"JS Ji","year":"2016","unstructured":"Ji, J. S., Xu, M., Song, J. J., Zhao, Z. W., Chen, M. J., Chen, W. Q., et al. (2016). Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: In vivo study. Oncotargets and Therapy, 9, 4357\u20134367.","journal-title":"Oncotargets and Therapy"},{"key":"669_CR31","doi-asserted-by":"publisher","DOI":"10.21037\/atm-2022-34","author":"E Office","year":"2022","unstructured":"Office, E. (2022). Erratum to miR-126\u20133p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1. Annals of Translational Medicine. https:\/\/doi.org\/10.21037\/atm-2022-34","journal-title":"Annals of Translational Medicine"},{"key":"669_CR32","doi-asserted-by":"publisher","first-page":"15472","DOI":"10.1073\/pnas.0707351104","volume":"104","author":"H Tazawa","year":"2007","unstructured":"Tazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proceedings of the National Academy of Sciences USA, 104, 15472\u201315477.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"669_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/sj.onc.1200886","volume":"14","author":"Z Kelman","year":"1997","unstructured":"Kelman, Z. (1997). PCNA: Structure, functions and interactions. Oncogene, 14, 629\u2013640.","journal-title":"Oncogene"},{"key":"669_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/CBM-170910","volume":"22","author":"S Wang","year":"2018","unstructured":"Wang, S., Cui, S., Zhao, W., Qian, Z., Liu, H., Chen, Y., et al. (2018). Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma. Cancer Biomarkers, 22, 631\u2013640.","journal-title":"Cancer Biomarkers"},{"key":"669_CR35","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.3390\/ijms22147477","volume":"22","author":"R Razpotnik","year":"2021","unstructured":"Razpotnik, R., Nassib, P., Kunej, T., Rozman, D., & Rezen, T. (2021). Identification of novel RNA Binding proteins influencing circular RNA expression in hepatocellular carcinoma. International Journal of Molecular Sciences, 22, 7477.","journal-title":"International Journal of Molecular Sciences"},{"key":"669_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.12.002","volume":"58","author":"E Arnaiz","year":"2019","unstructured":"Arnaiz, E., Sole, C., Manterola, L., Iparraguirre, L., Otaegui, D., & Lawrie, C. H. (2019). CircRNAs and cancer: Biomarkers and master regulators. Seminars in Cancer Biology, 58, 90\u201399.","journal-title":"Seminars in Cancer Biology"},{"key":"669_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ebiom.2018.07.036","volume":"34","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Yang, T., & Xiao, J. (2018). Circular RNAs: Promising biomarkers for human diseases. eBioMedicine, 34, 267\u2013274.","journal-title":"eBioMedicine"},{"key":"669_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3188","volume":"22","author":"WY Qin","year":"2020","unstructured":"Qin, W. Y., Feng, S. C., Sun, Y. Q., & Jiang, G. Q. (2020). MiR-96-5p promotes breast cancer migration by activating MEK\/ERK signaling. The Journal of Gene Medicine, 22, e3188.","journal-title":"The Journal of Gene Medicine"},{"key":"669_CR39","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.2147\/OTT.S248338","volume":"13","author":"X Luo","year":"2020","unstructured":"Luo, X., He, X., Liu, X., Zhong, L., & Hu, W. (2020). miR-96-5p suppresses the progression of nasopharyngeal carcinoma by targeting CDK1. Oncotargets and Therapy, 13, 7467\u20137477.","journal-title":"Oncotargets and Therapy"},{"key":"669_CR40","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.3748\/wjg.v25.i47.6823","volume":"25","author":"HY Zhou","year":"2019","unstructured":"Zhou, H. Y., Wu, C. Q., & Bi, E. X. (2019). MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma. World Journal of Gastroenterology, 25, 6823\u20136834.","journal-title":"World Journal of Gastroenterology"},{"key":"669_CR41","first-page":"1897","volume":"12","author":"H Tang","year":"2019","unstructured":"Tang, H., Liu, Y., Cheng, W., He, Z., & Zhou, N. (2019). microRNA-96-5p induces the epithelial-mesenchymal transition to promote the metastasis of hepatocellular carcinoma by post-transcriptionally downregulating Talin 1. International Journal of Clinical and Experimental Pathology, 12, 1897\u20131908.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"669_CR42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201097","volume":"218","author":"J Ablain","year":"2021","unstructured":"Ablain, J., Liu, S., Moriceau, G., Lo, R. S., & Zon, L. I. (2021). SPRED1 deletion confers resistance to MAPK inhibition in melanoma. Journal of Experimental Medicine, 218, e20201097.","journal-title":"Journal of Experimental Medicine"},{"key":"669_CR43","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200312","author":"W Liu","year":"2020","unstructured":"Liu, W., Fang, S., & Zuo, G. (2020). A study on the expression of SPRED1 and PBRM1 (Baf180) and their clinical significances in patients with gastric cancer. Clinical Laboratory. https:\/\/doi.org\/10.7754\/Clin.Lab.2020.200312","journal-title":"Clinical Laboratory"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00669-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T13:06:17Z","timestamp":1693832777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00669-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00669-3","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"20 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}